Social Capital Suvretta Holdings Corp. I
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $200M
- Underwriters
- Focus
- Biotech
- SEC Filings
- 1850266
- Public Embarc Page
- https://embarc.com/capital/spac/1850266/DNAA/social-capital-social-capital-suvretta-holdings-corp-i
- IPO Ticker
- DNAA
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and Chairman of the Board of DirectorsChamath Palihapitiya(Managing Partner of Social Capital, Chairman of Virgin Galactic)
- PresidentKishen Mehta
- DirectorVladimir Coric(CEO of Biohaven Pharmaceuticals)
- Chief Financial OfficerJames Ryans
- Director of ResearchShoney Katz
- President and DirectorKishan (a/k/a Kishen) Mehta
Target Information
Information on the SPAC target for merger.
- Company
- Akili Interactive
- Presentation
- Investor Presentation (SEC) on 2022-01-26
- New Ticker
- AKLI
- Description
- Akili is "a leading digital medicine company developing cognitive treatments through game-changing technologies."